Technical Analysis for ACAD - ACADIA Pharmaceuticals Inc.
Trend Table & Recent Alerts
|See historical ACAD trend table...|
|Date||Alert Name||Type||% Chg|
|Feb 21||Spinning Top||Other||0.92%|
|Feb 17||NR7||Range Contraction||0.71%|
|Feb 17||Narrow Range Bar||Range Contraction||0.71%|
|Feb 17||Golden Cross||Bullish||0.71%|
|Feb 17||Slingshot Bullish||Bullish Swing Setup||0.71%|
|Feb 15||1,2,3 Pullback Bullish||Bullish Swing Setup||0.23%|
|Feb 15||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||0.23%|
|Feb 15||Jack-in-the-Box Bullish||Bullish Swing Setup||0.23%|
|Feb 14||Wide Range Bar||Range Expansion||-0.33%|
|Feb 14||1,2,3 Pullback Bullish||Bullish Swing Setup||-0.33%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The company has a pipeline of product candidates led by pimavanserin, which is in Phase III development stage for the treatment of Parkinson's disease psychosis. It is also developing pimavanserin that has completed Phase II co-therapy trials for the treatment of schizophrenia; and is in Phase II clinical trials for the treatment of Alzheimers disease psychosis. In addition, the company, through collaboration with Allergan, Inc., is developing alpha adrenergic agonists, which are in Phase II clinical trials for the treatment of chronic pain; and muscarinic agonist that is in Phase I clinical trials for the treatment of glaucoma. Further, it is developing two advanced preclinical programs directed at Parkinsons disease and other neurological disorders. The company was formerly known as Receptor Technologies, Inc. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Is ACAD a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ACAD news...
|52 Week High||42.49|
|52 Week Low||17.02|
|200-Day Moving Average||31.81|
|50-Day Moving Average||32.41|
|20-Day Moving Average||36.96|
|10-Day Moving Average||38.78|
|Average True Range||1.52|
|Chandelier Exit (Long, 3 ATRs)||36.27|
|Chandelier Exit (Short, 3 ATRs)||33.68|
|Upper Bollinger Band||42.2|
|Lower Bollinger Band||31.72|
|Percent B (%b)||0.75|